A large, blood-based profiling study accurately identified clonal hematopoiesis (CH) variants, effectively decreasing clinical false positives missed by other plasma...
STRATFORD, Conn., Feb. 11, 2025 /PRNewswire/ -- KUBTEC®, a global leader in pathology specimen imaging technology, has proudly launched The...
Investment Powers the Debut of Pyxa: A Groundbreaking Platform for 3D Spatial Biology Research BOSTON, Feb. 11, 2025 /PRNewswire/ -- Stellaromics,...
Minneapolis, MN, Feb. 11, 2025 (GLOBE NEWSWIRE) -- United Theranostics, a leading provider of radiopharmaceutical therapy and supportive molecular imaging...
UK regulatory approval follows FemaSeed, FemVue and FemCerv clearance/ approvals in the U.S., Europe, Canada and IsraelATLANTA, Feb. 11, 2025...
Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss...
PASADENA, CALIF., Feb. 11, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW),...
SEATTLE and VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical...
CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M in Bitcoin, Solana...
BRISBANE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical...
February 11-12, 2025, Snowbird, UtahIRVINE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology...
National Coalition Works to Expand Early, Equitable Access to Supportive Cancer CareSALT LAKE CITY, Feb. 11, 2025 (GLOBE NEWSWIRE) --...
Updated Screening Guidelines Ensure Broader Access to Colorectal Cancer Screening in GermanyBERKELEY, Calif. and MAINZ, Germany, Feb. 11, 2025 (GLOBE...
PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery...
100% of acute myeloid leukemia (AML) patients across both original and expansion cohorts remain in complete remission (CR), with a...
Dr. Hege joins the Board as EvolveImmune prepares to enter the clinic in mid-2025 with EVOLVE104, its lead trispecific T...
Medicus Pharma Ltd.'s shares will remain listed on the NASDAQ Capital MarketToronto, Ontario and Philadelphia, Pennsylvania--(Newsfile Corp. - February 11,...
Flatiron’s high-quality real-world data and innovative artificial intelligence-based extraction are generating novel learnings on treatment safety and patterns for people...
Flatiron’s high-quality real-world data and innovative artificial intelligence-based extraction are generating novel learnings on treatment safety and patterns for people...
MIAMI, Feb. 10, 2025 /PRNewswire/ -- The Digital Safety Alliance (DSA) is proud to celebrate its one-year anniversary with the...